+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Topical Haemostat Market (2023-2028) by Product, Application, End User, and Geography, Competitive Analysis, Impact of Economic Slowdown & Impending Recession with Ansoff Analysis

  • PDF Icon


  • 217 Pages
  • January 2023
  • Region: Global
  • Infogence Global Research
  • ID: 5753531
The Global Topical Hemostat Market is estimated to be USD 3.6 Bn in 2023 and is expected to reach USD 4.79 Bn by 2028, growing at a CAGR of 5.90%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding growth and reducing the risks.

Market Segmentations

The Global Topical Hemostat Market is segmented based on Product, Application, End User, and Geography.
  • By Product, the market is classified into Active Hemostats, Passive Hemostats, Combination Hemostats, and Others.
  • By Application, the market is classified into Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, and Others.
  • By End User, the market is classified into Hospitals & ASCs, Tactical Combat Casualty Care Centers, and Others.
  • By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Johnson & Johnson, Becton Dickinson & Co, Baxter International, Inc., Pfizer, Inc., B. Braun Melsungen Ag, Teleflex, Inc., Medtronic plc, Gelita Ag, Teleflex, Inc., Meril Life Sciences Pvt Ltd, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Topical Hemostat Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Topical Hemostat Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Topical Hemostat Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth Market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the Market are also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains a competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Analyst Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook

4 Market Dynamics
4.1 Drivers
4.1.1 Potential Demand in Vascular Surgeries across the World
4.1.2 Increasing Application Attributed to Its Cost-Effective Nature
4.1.3 Growing Aging Population and Related Infections
4.2 Restraints
4.2.1 Dearth of Reimbursement Policies for these Products
4.3 Opportunities
4.3.1 Emerging Demand for Minimally Invasive Surgical Procedures
4.3.2 Ongoing R&D for the Introduction of Novel Topical Hemostat
4.4 Challenges
4.4.1 High Cost of Surgical Procedures

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTEL Analysis
5.4 SWOT Analysis
5.5 Impact of COVID-19
5.6 Impact of Economic Slowdown & Impending Recession
5.7 Ansoff Matrix Analysis

6 Global Topical Hemostat Market, By Product
6.1 Introduction
6.2 Active Hemostats
6.2.1 Thrombin-based Hemostats
6.2.2 Fibrin Sealants
6.3 Passive Hemostats
6.3.1 Plant-based Hemostats
6.3.2 Animal-based Hemostats
6.3.3 Others
6.4 Combination Hemostats
6.5 Others

7 Global Topical Hemostat Market, By Application
7.1 Introduction
7.2 Trauma
7.3 Cardiovascular Surgery
7.4 General Surgery
7.5 Plastic Surgery
7.6 Orthopedic Surgery
7.7 Neurosurgery
7.8 Others
8 Global Topical Hemostat Market, By End User
8.1 Introduction
8.2 Hospitals & ASCs
8.3 Tactical Combat Casualty Care Centers
8.4 Others
9 Global Topical Hemostat Market, By Application
9.1 Introduction

10 Americas' Topical Hemostat Market
10.1 Introduction
10.2 Argentina
10.3 Brazil
10.4 Canada
10.5 Chile
10.6 Colombia
10.7 Mexico
10.8 Peru
10.9 United States
10.10 Rest of Americas

11 Europe's Topical Hemostat Market
11.1 Introduction
11.2 Austria
11.3 Belgium
11.4 Denmark
11.5 Finland
11.6 France
11.7 Germany
11.8 Italy
11.9 Netherlands
11.10 Norway
11.11 Poland
11.12 Russia
11.13 Spain
11.14 Sweden
11.15 Switzerland
11.16 United Kingdom
11.17 Rest of Europe

12 Middle East and Africa's Topical Hemostat Market
12.1 Introduction
12.2 Egypt
12.3 Israel
12.4 Qatar
12.5 Saudi Arabia
12.6 South Africa
12.7 United Arab Emirates
12.8 Rest of MEA

13 APAC's Topical Hemostat Market
13.1 Introduction
13.2 Australia
13.3 Bangladesh
13.4 China
13.5 India
13.6 Indonesia
13.7 Japan
13.8 Malaysia
13.9 Philippines
13.10 Singapore
13.11 South Korea
13.12 Sri Lanka
13.13 Thailand
13.14 Taiwan
13.15 Rest of Asia-Pacific

14 Competitive Landscape
14.1 Competitive Quadrant
14.2 Market Share Analysis
14.3 Strategic Initiatives
14.3.1 M&A and Investments
14.3.2 Partnerships and Collaborations
14.3.3 Product Developments and Improvements

15 Company Profiles
15.1 Aegis Lifesciences
15.2 Arch Therapeutics, Inc.
15.3 Axio Biosolutions Pvt Ltd
15.4 B. Braun Melsungen Ag
15.5 Baxter International, Inc.
15.6 Becton Dickinson & Co
15.7 Cohera Medical, Inc.
15.8 CryoLife, Inc.
15.9 Equimedical B.V.
15.10 Ethicon LLC.
15.11 Gelita Ag
15.13 Hemostasis, LLC
15.14 Integra LifeSciences Corp.
15.15 Johnson & Johnson
15.16 Medtronic plc
15.17 Meril Life Sciences Pvt Ltd
15.18 Pfizer, Inc.
15.19 Stryker Corp.
15.20 Teleflex, Inc.

16 Appendix
16.1 Questionnaire

Companies Mentioned

  • Aegis Lifesciences
  • Arch Therapeutics, Inc.
  • Axio Biosolutions Pvt Ltd
  • B. Braun Melsungen Ag
  • Baxter International, Inc.
  • Becton Dickinson & Co
  • Cohera Medical, Inc.
  • CryoLife, Inc.
  • Equimedical B.V.
  • Ethicon LLC.
  • Gelita Ag
  • Hemostasis, LLC
  • Integra LifeSciences Corp.
  • Johnson & Johnson
  • Medtronic plc
  • Meril Life Sciences Pvt Ltd
  • Pfizer, Inc.
  • Stryker Corp.
  • Teleflex, Inc.

Table Information